Literature DB >> 8714529

Vision in dementia: contrast effects.

V Lakshminarayanan1, J Lagrave, M L Kean, M Dick, R Shankle.   

Abstract

Contrast sensitivity has been shown to be affected in Alzheimer's disease (Ad). We investigated low contrast acuity and contrast sensitivity using clinical test charts in this patient population. Additionally, we tested patients with vascular dementia (vd) and mixed dementia (md), (Alzheimer' with vascular dementia). Contrast sensitivity was assessed using the Vistech VCTS 6500 test chart. Low contrast acuity was measured using the Regan charts at four contrast levels (96%, 50%, 25% and 11%). The patient population consisted of 19 Ad patients, 9 vd patients and 10 md patients. Reduction in acuity was found with contrast level in all cases. Regression lines were fit to the data and statistical analysis was performed. We did not find a statistically significant difference between the Ad and vd or md groups. We did, however, find a difference between the vd and md groups. We did find reduction in contrast sensitivity at all spatial frequencies when compared to the elderly normal. Correspondingly, we found a significant difference in acuity when compared with normal data at the four contrast levels tested. Acuity is reduced with contrast in all patient groups. Our contrast sensitivity results are similar to those reported in the literature. This study points out the importance of using simple clinical test charts and further underscores the idea that there is a primary visual deficit in Ad.

Entities:  

Mesh:

Year:  1996        PMID: 8714529     DOI: 10.1080/01616412.1996.11740369

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  13 in total

1.  Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.

Authors:  F Sartucci; D Borghetti; T Bocci; L Murri; P Orsini; V Porciatti; N Origlia; L Domenici
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

2.  Early Alzheimer's disease blocks responses to accelerating self-movement.

Authors:  Roberto Fernandez; Charles J Duffy
Journal:  Neurobiol Aging       Date:  2012-02-17       Impact factor: 4.673

Review 3.  A systematic survey of advances in retinal imaging modalities for Alzheimer's disease diagnosis.

Authors:  Richa Vij; Sakshi Arora
Journal:  Metab Brain Dis       Date:  2022-03-15       Impact factor: 3.655

4.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

5.  Ocular manifestations of Alzheimer's disease in animal models.

Authors:  Miles Parnell; Li Guo; Mohamed Abdi; M Francesca Cordeiro
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

Review 6.  Myeloid cells in retinal and brain degeneration.

Authors:  Michelle Guo; Turner D Schwartz; Joshua L Dunaief; Qi N Cui
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

7.  Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.

Authors:  Elena Salobrar-Garcia; Rosa de Hoz; Blanca Rojas; Ana I Ramirez; Juan J Salazar; Raquel Yubero; Pedro Gil; Alberto Triviño; José M Ramirez
Journal:  J Ophthalmol       Date:  2015-05-27       Impact factor: 1.909

8.  Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.

Authors:  S Frost; Y Kanagasingam; H Sohrabi; J Vignarajan; P Bourgeat; O Salvado; V Villemagne; C C Rowe; S Lance Macaulay; C Szoeke; K A Ellis; D Ames; C L Masters; S Rainey-Smith; R N Martins
Journal:  Transl Psychiatry       Date:  2013-02-26       Impact factor: 6.222

9.  Alzheimer's disease: screening biomarkers using frequency doubling technology visual field.

Authors:  Denise A Valenti
Journal:  ISRN Neurol       Date:  2013-09-25

Review 10.  Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression.

Authors:  Fatimah Zara Javaid; Jonathan Brenton; Li Guo; Maria F Cordeiro
Journal:  Front Neurol       Date:  2016-04-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.